nCino, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data nCino, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	138	204	274	408	477	541	595
Cost of revenue	64.1	88.1	111	170	191	216	235
Gross profit	74.1	116	162	239	285	325	360
Research and development	35.3	58.3	79.4	122	117	129	128
Selling and marketing	44.4	59.7	82.9	128	131	123	137
General and administrative	22.5	40.8	71.5	83.5	76.7	90.3	92.4
Operating expenses	102	159	234	333	325	343	356
Operating income	-28.2	-42.6	-71.4	-94	-39.5	-18.1	3.73
Interest expense	0	0.13	1.51	2.81	4.14	8.76	17.5
Interest income	0.99	0.36	0.19	0.4	2.57	1.76	1.43
Other non-operating income	0.03	1.69	-1.28	-1.36	-0.86	-10.4	19
Pre-tax income	-27.1	-40.7	-74	-97.8	-41.9	-35.6	6.71
Income tax	0.59	0.59	-23.8	4.07	1.59	-2.51	-3
Net income to minority interests	-0.14	-1.13	-1.57	-1.12	-1.11	-0.47	0.14
Net income	-27.6	-40.5	-49.4	-103	-42.3	-37.9	5.18
EBITDA	-23.6	-35.2	-61.4	-59.4	5.75	18.2	46
EPS, basic	-0.35	-0.46	-0.51	-0.93	-0.38	-0.33	0.05
EPS, diluted	-0.35	-0.46	-0.51	-0.93	-0.38	-0.33	0.05
Shares, basic (weighted)	78.3	87.7	96.7	111	113	115	113
Shares, diluted (weighted)	78.3	87.7	96.7	111	113	115	114

Balance sheet

	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	91.2	371	88	82	112	121	88.4
Receivables		55.5	74.5	99.5	113	147	167
Other current assets		10.4	13.4	16.3	15.2	1.34	2.13
Total current assets		442	184	207	251	302	294
Property, plant and equipment		29.9	60.7	84.4	79.1	75	75.6
Lease right-of-use assets		0	13.2	10.5	19.3	16	12.7
Goodwill	55.8	57.1	841	839	839	1,019	1,078
Intangible assets		23.1	180	153	116	155	136
Long-term investments		0	4.03	6.53	9.29	9.29	7.26
Other non-current assets		0.75	1.62	8.1
Total assets		563	1,301	1,327	1,340	1,610	1,648
Accounts payable		1.63	11.4	11.9	11.8	13.6	14.5
Accrued liabilities			21.5	22.6	16.3	23.6	24.8
Deferred revenue		89.1	123	155	171	191	211
Short-term debt							0
Total current liabilities		116	174	205	215	252	294
Long-term debt							214
Lease liabilities		0	11.2	7.28	16.4	12.8	9.75
Other non-current liabilities					0	17.2	4.12
Total liabilities		134	231	300	288	513	579
Total debt							214
Paid-in capital		586	1,277	1,334	1,401	1,474	1,550
Retained earnings		-161	-210	-310	-353	-385	-376
Treasury stock						0	-126
Other comprehensive income		0.24	-0.07	0.69	1	0.18	7.04
Shareholders' equity	167	425	1,068	1,024	1,049	1,089	1,056
Total equity	167	425	1,068	1,024	1,049	1,089	1,056
Total liabilities and equity		563	1,301	1,327	1,340	1,610	1,648
Shares outstanding		93.6	110	111	114	116	114

Cash flow statement

	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-27.7	-41.3	-50.1	-102	-43.5	-33	9.7
Depreciation and amortization	4.61	7.43	10	34.7	45.3	36.3	42.3
Stock-based compensation	5.75	25.2	28.5	50.2	58	71.6	73.9
Deferred income tax	0.16	0.17	-24.3	1.63	-2.34	-7.12	-6.19
Change in receivables	-9.29	-20.6	-13.5	-26.8	-14.3	-31.4	-16.2
Change in payables	-0.07	0.35	8.8	0.04	0.53	-0.19	1.11
Cash from operations	-9	9.22	-19.2	-15.4	57.3	55.2	90.1
Capital expenditures	-5.76	-4.34	-5.46	-18.3	-3.52	-1.82	-7.5
Acquisitions	-52.3	0	-269	0.68	0	-217	-50.3
Purchases of investments	0	0	-4.03	-2.5	-2.5	0	0
Cash from investing	-58	-4.34	-278	-20.7	-6.33	-219	-54.1
Stock issued	80	0	0	3.75	4.47	2.8	1.98
Share buybacks					0	0	-125
Cash from financing	84.1	274	15.9	36.7	-21.1	170	-73
Exchange rate effect	-0.23	1.24	-1.23	-1.59	0.18	-2.68	4.47
Net change in cash	16.8	280	-283	-0.98	30	3.82	-32.6
Free cash flow	-14.8	4.88	-24.7	-33.7	53.8	53.4	82.6
Interest paid	0	0.13	1.51	2.62	4.32	8.75	16
Income taxes paid	0.37	0.63	1	0.66	3.2	3.6	4.37

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $19.41 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	62.2%	Gross profit / revenue.
Operating margin	7.9%	Operating income / revenue.
EBITDA margin	11.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	5.4%	Net income / revenue.
FCF margin	21.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	21.5%	Cash from operations / revenue.
Return on equity (ROE)	3.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.1%	Net income / average total assets.
Return on invested capital (ROIC)	3.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	19.2%	Research and development expense / revenue.
Stock-based pay / revenue	11.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.2%	Capital expenditures / revenue.
D&A / revenue	3.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	10.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	13.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	23.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	10.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	14.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	25.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	152.5%	EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	63.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	57.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	54.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	76.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-3.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	1.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	20.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	23.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	5.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.85x	Current assets / current liabilities.
Quick ratio	0.72x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.29x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.30x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	17.5%	Total debt / total assets.
Liabilities / assets	39.9%	Total liabilities / total assets.
Net debt	$192.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.66x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.70x	Operating income / interest expense.
Working capital	-$43.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	75.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$263.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.40x	Revenue / average total assets.
Fixed asset turnover	8.45x	Revenue / average property, plant and equipment.
Receivables turnover	5.09x	Revenue / average receivables.
Days sales outstanding	72 days	365 x average receivables / revenue.
Days payables	23 days	365 x average accounts payable / cost of revenue.
FCF conversion	393.4%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	1.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.32	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$5.91	Revenue / diluted weighted shares.
FCF per share	$1.25	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.27	Cash from operations / diluted weighted shares.
Book value per share	$8.84	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$2.50	Tangible book value / shares outstanding.
Cash per share	$0.79	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	181.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.13B	Share price x shares outstanding.
Enterprise value	$2.32B	Market cap + total debt - cash - short-term investments.
P/E	63.3x	Market cap / net income. Only when net income is positive.
P/S	3.42x	Market cap / revenue.
P/B	2.29x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	16.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	15.9x	Market cap / cash from operations, when positive.
EV/Sales	3.73x	Enterprise value / revenue.
EV/EBIT	47.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	32.1x	Enterprise value / EBITDA, when both are positive.
EV/FCF	17.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.2%	Free cash flow / market cap.
Earnings yield	1.6%	Net income / market cap (the inverse of P/E).
Shareholder yield	11.3%	(Dividends paid + share buybacks) / market cap.

What was nCino, Inc.'s revenue in fiscal 2026?

nCino, Inc. reported revenue of $594.8M for fiscal 2026, 10% higher than the year before.

Was nCino, Inc. profitable in fiscal 2026?

Yes. Net income was $5.2M, a net margin of 0.9%.

How much free cash flow did nCino, Inc. generate in fiscal 2026?

Cash from operations of $90.1M minus capital expenditures of $7.5M left free cash flow of $82.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to nCino, Inc.